PremiumCompany AnnouncementsLTR Pharma’s SPONTAN® Set to Disrupt ED Market with Breakthrough Clinical Data LTR Pharma Limited Releases Half-Year Financial Report LTR Pharma’s Breakthrough in Erectile Dysfunction Treatment and Strategic Expansions PremiumCompany AnnouncementsLTR Pharma Eyes Investors with New Nasal Spray LTR Pharma Plans Major Share Issue on ASX LTR Pharma Secures Funding for U.S. Launch of SPONTAN PremiumCompany AnnouncementsLTR Pharma’s AGM Success and Market Potential LTR Pharma’s Year of Breakthroughs and Strategic Growth LTR Pharma’s AGM to Highlight Innovative ED Treatment